The Lancet Respiratory Medicine· Simon Couillard, Fleur L Meulmeester, Pascal Charland, Samuel Lemaire-Paquette, Imran Howell, Carlos Celis-Preciado, Philippe Lachapelle, Liam G Heaney, Peter Bradding, Samuel Mailhot-Larouche, Sanjay Ramakrishnan, Michael E Wechsler, Guy Brusselle, Sarah E Diver, Christopher E Brightling, Mario Castro, Nicola A Hanania, David J Jackson, Neil Martin, Alison Moore, Peter Howarth, Megan E Hardin, Rebecca Gall, Cecile T J Holweg, Vennila Dharman, Richard W Beasley, Jacob K Sont, Ewout W Steyerberg, Ian D Pavord, The Oxford Asthma Attack Risk Scale Meta-analysis (ORACLE2) Consortium·· 2026-08-21AI 评分58
个体患者Meta分析:哮喘症状负担与其他临床、生理及生物学特征一致性有限
[Articles] Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
AI 导读
一项汇总随机对照试验与转化前瞻性观察队列的个体患者水平Meta分析显示,哮喘症状负担与其他临床、生理或生物学特征一致性有限,对重度急性发作的预测价值一般。相比之下,2型生物标志物在识别高风险患者及可能对治疗有反应者方面更可靠。研究提示症状或需结合具体情境解读,以指导哮喘抗炎治疗升级。
来源:The Lancet Respiratory Medicine · thelancet.com